Mesa Laboratories (MLAB) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US59064R1095
Mesa Laboratories, Inc. is a global company that specializes in developing, manufacturing, and selling life sciences tools and quality control products and services across North America, Europe, Asia Pacific, and internationally. It operates in four key segments, offering a wide range of solutions to different industries.
Within the Clinical Genomics segment, Mesa Laboratories develops and sells genetic analysis tools tailored for clinical labs, including the MassARRAY system, chips, panels, and chemical reagent solutions. These tools are utilized for genomic clinical testing in areas such as hereditary diseases, pharmacogenetics, and oncology applications.
The Sterilization and Disinfection Control segment focuses on manufacturing biological, cleaning, and chemical indicators to assess the efficiency of sterilization and disinfection processes in various industries like hospitals, dental care, medical devices, and pharmaceuticals. Additionally, this segment provides testing services mainly to the dental sector.
In the Biopharmaceutical Development segment, Mesa Laboratories offers automated systems for protein analysis and peptide synthesis solutions. These solutions help in automating the chemical synthesis of peptides essential for peptide therapies, biomaterials, cosmetics, and research purposes.
The Calibration Solutions segment specializes in designing and marketing quality control products for measuring and calibrating temperature, pressure, pH, humidity, and other factors crucial for health and safety across hospital settings, medical device manufacturing, pharmaceutical manufacturing, and laboratories. Its product range includes continuous monitoring systems, data loggers, gas flow calibration equipment, and torque testing systems.
Founded in 1982, Mesa Laboratories continues to innovate and provide essential products and services to various industries, ensuring quality control and safety measures. To learn more about Mesa Laboratories, visit their website: https://www.mesalabs.com.
Drawdown (Underwater) Chart
MLAB Stock Overview
| Market Cap in USD | 540m |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| GiC SubIndustry | Life Sciences Tools & Services |
| TER | 0.00% |
| IPO / Inception | 1995-01-25 |
MLAB Stock Ratings
| Growth 5y | -4.46 |
| Fundamental | 1.01 |
| Dividend | 5.01 |
| Rel. Performance vs Sector | -5.44 |
| Analysts | 4.33/5 |
| Fair Price Momentum | 87.40 USD |
| Fair Price DCF | 211.07 USD |
MLAB Dividends
| Yield 12m | 0.61% |
| Yield on Cost 5y | 0.28% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 97.0% |
MLAB Growth Ratios
| Growth 12m | -34.74% |
| Growth Correlation 12m | -48% |
| Growth Correlation 3m | 26% |
| CAGR 5y | -14.65% |
| Sharpe Ratio 12m | -0.87 |
| Alpha vs SP500 12m | -57.60 |
| Beta vs SP500 5y weekly | 0.82 |
| ValueRay RSI | 72.61 |
| Volatility GJR Garch 1y | 48.38% |
| Price / SMA 50 | -0.08% |
| Price / SMA 200 | -3.01% |
| Current Volume | 19.6k |
| Average Volume 20d | 37.5k |
External Links for MLAB Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 25, 2024, the stock is trading at USD 104.47 with a total of 19,558 shares traded.
Over the past week, the price has changed by +3.29%, over one month by +4.60%, over three months by +12.23% and over the past year by -41.18%.
According to ValueRays Forecast Model, MLAB Mesa Laboratories will be worth about 95.3 in April 2025. The stock is currently trading at 104.47. This means that the stock has a potential downside of -8.76%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 127 | 21.6 |
| Analysts Target Price | 139 | 33.1 |
| ValueRay Target Price | 95.3 | -8.76 |